← TagsCompany

SenesTech Inc

SenesTech, Inc. develops a technology for managing animal pest populations by controlling fertility. The company is headquartered in Phoenix, Arizona.

128 articles

SenesTech Adds JoAnna Abrams to Board of Directors

SenesTech Inc. appointed JoAnna Abrams to its Board of Directors effective November 16, 2026. The appointment expands the board to eight members to leverage her consumer brand and product intelligence

StreetInsider · 2026-11-17 14:00

SenesTech Inc Files Form 8K on November 17

SenesTech Inc submitted a Form 8K regulatory filing on November 17, indicating potential significant company news relevant to financial markets.

Investing.com India · 2026-11-17 13:00

SenesTech Inc. CEO Files Form 4 on September 14

SenesTech Inc. CEO Michael Edell filed a Form 4 disclosure on September 14, confirming insider activity for the biotech company focused on biopesticides and senolytic therapies.

Investing.com Canada · 2026-11-16 01:58

SenesTech CEO Michael Edell Buys $840 of Company Stock

SenesTech CEO Michael Edell purchased 1,000 shares for $840 on September 14, 2026, increasing ownership to 9,000 shares following strong Q3 revenue growth despite recent stock declines.

Investing.com Canada · 2026-11-15 23:58

SenesTech (SNES) Q3 2026 Earnings Call Transcript

SenesTech reported record Q3 2026 revenues of $1.1 million, a 59% year-over-year increase driven by e-commerce growth and subscription customers for its rodent birth control products.

The Globe and Mail · 2026-11-11 05:11

SenesTech, Inc. (SNES) Tops Q3 EPS by 2c

SenesTech reported Q3 earnings with an EPS of ($0.36), beating analyst estimates by $0.02, while revenue reached $1.1 million against a consensus of $694.5 thousand.

StreetInsider · 2026-11-10 22:00

SenesTech, Inc. Estimates – NASDAQ:SNES

Overview of SenesTech Inc financials and analyst estimates on TradingView, covering reported financial data and trends with standard investment disclaimers.

TradingView · 2026-10-27 19:40

SenesTech Inc Files Form 8K on October 22

SenesTech Inc filed a Form 8K on October 22, 2026, resulting in a 6.53% stock price increase. The filing is considered a significant corporate event for the biotechnology firm.

Investing.com Canada · 2026-10-22 12:42

Glenbrook Crosses 30% Ownership Stake in SenesTech

Glenbrook Capital Management has acquired over 30% of SenesTech, urging improved market strategy and capital discipline while engaging Sandstrom Partners for branding assistance.

TradingView · 2026-10-19 19:11